Search Results 1411-1420 of 20057 for Hepatitis C

1. Clinical Core - Mayo Clinic Research

   Center for Cell Signaling in Gastroenterology (C-SiG). Sections. Overview; About About. Governance · Faculty. Cores & Services Cores & Services. Clinical Core ...

2. A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis - Mayo Clinic

   laboratory. Participants with chronic hepatitis C virus (HCV) (ie, positive HCV antibody [HCVAb] and HCV RNA). Note: Subjects who are HCVAb-positive without ...

3. To Assess Safety, Tolerability And Efficacy Of LJN452 In Patients With Primary Bile Acid Diarrhea. - Mayo Clinic

   A positive Hepatitis B surface antigen or Hepatitis C test result. History of immunodeficiency diseases, including a positive HIV (ELISA and Western blot) ...

4. Tocilizumab In The Treatment Of Refractory Polymyositis And Dermatomyositis - Mayo Clinic

   Positive hepatitis BsAg or hepatitis C antibody. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most ...

5. Investigation Of Ubamatamab Combination Therapy In Adult Participants With Platinum-Resistant Ovarian Cancer - Mayo Clinic

   Uncontrolled infections including but not limited to human immunodeficiency virus, hepatitis B or hepatitis C infection, or diagnosis of immunodeficiency NOTE: ...

6. Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L Biliary Tract Cancer (BTC) - Mayo Clinic

   Participants receiving active hepatitis C ... Active bacterial, fungal, or viral infection (with the exception of hepatitis B and hepatitis C) requiring systemic ...

7. Open-Label Study of PEGPH20 With CIS and GEM; PEGPH20 With Atezolizumab, CIS and GEM; and Compared With CIS and GEM Alone in HA-high Subjects With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma - Mayo Clinic

   Active hepatitis B virus (HBV) infection, defined as having a positive hepatitis B surface antigen (HBsAg) test at screening. Active hepatitis C virus ...

8. Safety and Efficacy of IMM 124-E for Patients with Severe Alcoholic Hepatitis - Mayo Clinic

   ... hepatitis (SAH). Aim: To perform a phase 2a "proof of concept" placebo-controlled, dose-ranging study of Imm 124-E (hyperimmune bovine colostrum enriched ...

9. A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis - Mayo Clinic

   History of chronic active hepatitis including active or chronic hepatitis B, or acute or chronic hepatitis C. History of tuberculosis (TB) infection, any ...

10. Mayo Clinic Transplant Center - Doctors

    Displaying 11-14 out of 14 doctors available. Last Name Initial: C. Alex Cortez, M.D.. Transplant Surgeon.